Lv52
1316 积分 2025-09-28 加入
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials
18天前
已完结
Exploring the rates of Gastrointestinal adverse effects among five GLP-1 receptor agonists: A systematic review and Meta-Analysis of randomized controlled trials
25天前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
26天前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
27天前
已完结
Lean Mass Changes With Incretin Therapy Versus Lifestyle Intervention: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
1个月前
已完结
Human Amylin: From Pathology to Physiology and Pharmacology
1个月前
已完结
Gastrointestinal adverse events associated with GLP-1 receptor agonists in metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis
1个月前
已完结
Contemporary medical, device, and surgical therapies for obesity in adults
1个月前
已完结
GLP-1-based therapies for diabetes, obesity and beyond
1个月前
已完结
Peptide GLP-1 receptor agonists: From injection to oral delivery strategies
1个月前
已完结